IRLAB Therapeutics AB (publ) (STO:IRLAB.A)

IRLAB Therapeutics AB Statistics

Total Valuation

STO:IRLAB.A has a market cap or net worth of SEK 161.21 million. The enterprise value is 80.89 million.

Market Cap	161.21M
Enterprise Value	80.89M

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:IRLAB.A has 84.94 million shares outstanding. The number of shares has increased by 13.14% in one year.

Current Share Class	84.86M
Shares Outstanding	84.94M
Shares Change (YoY)	+13.14%
Shares Change (QoQ)	+51.98%
Owned by Insiders (%)	13.85%
Owned by Institutions (%)	19.77%
Float	66.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.88
PB Ratio	2.97
P/TBV Ratio	21.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.88
EV / Sales	0.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.55.

Current Ratio	1.30
Quick Ratio	1.30
Debt / Equity	0.55
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.83

Financial Efficiency

Return on equity (ROE) is -199.29% and return on invested capital (ROIC) is -49.63%.

Return on Equity (ROE)	-199.29%
Return on Assets (ROA)	-27.35%
Return on Invested Capital (ROIC)	-49.63%
Return on Capital Employed (ROCE)	-89.89%
Revenue Per Employee	2.76M
Profits Per Employee	-2.96M
Employee Count	31
Asset Turnover	0.52
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.10% in the last 52 weeks. The beta is 0.59, so STO:IRLAB.A's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-87.10%
50-Day Moving Average	2.10
200-Day Moving Average	3.95
Relative Strength Index (RSI)	38.97
Average Volume (20 Days)	130,907

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:IRLAB.A had revenue of SEK 85.56 million and -91.91 million in losses. Loss per share was -1.57.

Revenue	85.56M
Gross Profit	-30.63M
Operating Income	-72.40M
Pretax Income	-91.91M
Net Income	-91.91M
EBITDA	-71.69M
EBIT	-72.40M
Loss Per Share	-1.57

Balance Sheet

The company has 110.13 million in cash and 29.81 million in debt, with a net cash position of 80.33 million or 0.95 per share.

Cash & Cash Equivalents	110.13M
Total Debt	29.81M
Net Cash	80.33M
Net Cash Per Share	0.95
Equity (Book Value)	54.21M
Book Value Per Share	0.64
Working Capital	27.16M

Cash Flow

Operating Cash Flow	-53.64M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is -35.80%, with operating and profit margins of -84.62% and -107.43%.

Gross Margin	-35.80%
Operating Margin	-84.62%
Pretax Margin	-107.43%
Profit Margin	-107.43%
EBITDA Margin	-83.79%
EBIT Margin	-84.62%
FCF Margin	n/a

Dividends & Yields

STO:IRLAB.A does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.14%
Shareholder Yield	-13.14%
Earnings Yield	-57.01%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 28, 2019. It was a forward split with a ratio of 5.

Last Split Date	May 28, 2019
Split Type	Forward
Split Ratio	5

Scores

STO:IRLAB.A has an Altman Z-Score of -4.48 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.48
Piotroski F-Score	4